TNF inhibitor exposure in patients with autoimmune diseases such as RA appears to be associated with an increased risk of inflammatory demyelinating CNS events such as optic neuritis, a new study has shown. The US nested case control study also found that TNF inhibitors were associated with non-demyelinating CNS events such as meningitis and meningoencephalitis. ...
Inflammatory demyelinating CNS events seen with TNF inhibitors
By Michael Woodhead
20 May 2020